Ritter Pharmaceuticals Inc (RTTR)

[Tadaaa]

RTTR: Dr. William Chey Highlights Phase 3 Drug Candidate RP-G28 in

Dr. Chey added that by supporting the growth of bacteria strains necessary to address a specific disease state, selective “prebiotics” such as RP-G28 represent a possibly game-changing approach to addressing lactose intolerance as well as other diseases. “To me, that's the really exciting part of this whole thing; to see if this strategy of manipulating the microbiome to affect symptoms of lactose intolerance holds true. Because if it does, this could be the beginning of something really big.”

https://ih.advfn.com/stock-market/NASDAQ/ritter-pharmaceuticals-inc-RTTR/stock-news/79369765/dr-william-chey-highlights-unmet-medical-need-of

GLTA !!